Back

GLP-1 receptor agonists and atherosclerosis: a metabolic treatment for a cardiometabolic disease

European Heart Journal

7 April 2026
Organised by: Logo
Read full article
ESC Journals CARDIOVASCULAR PHARMACOLOGY BASIC SCIENCE

Contributors

Georgios Georgiopoulos
Georgios Georgiopoulos

Author

Simon Kraler
Simon Kraler

Author

Bern University Hospital, Inselspital Bern , Switzerland

Kimon Stamatelopoulos
Kimon Stamatelopoulos

Author

You may be interested in
thumbnail
Congress Presentation
Effects of the glucagon like peptide-1 receptor analogue, sodium-glucose co-transporter 2 and their combination on myocardial work index and vascular function in diabetes after 3-month treatment
3 September 2019
thumbnail
ESC TV Today
Episode 26: Lp(a): the future starts now - Myocardial infarction in older age and frailty
6 November 2025
thumbnail
Congress Presentation
GLP-1 receptor agonists as an opportunity for patients with atherosclerotic cardiovascular disease as well as obesity in Germany
1 September 2025
thumbnail
Congress Presentation
GLP1 receptor agonists and CAD regression in diabetic patients after ACS
31 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources